Characteristics of the Marginal Zone Lymphomas
| Case . | Site of Primary Involvement . | Age/Sex . | Immunophenotype . | |||||
|---|---|---|---|---|---|---|---|---|
| CD20 . | CD5 . | IgM . | IgD . | κ . | λ . | |||
| 1 | Spleen | 65/M | + | − | + | − | + | − |
| 2 | Spleen | 71/M | + | − | + | − | + | − |
| 3 | Spleen | 52/M | + | − | + | − | + | − |
| 4 | Spleen | 69/M | + | − | + | +/− | − | + |
| 5 | Lymph node | 84/M | + | − | +/− | − | − | + |
| 6 | Lymph node | 55/F | + | − | +/− | − | − | + |
| 7 | Lymph node | 65/M | + | − | + | − | + | − |
| 8 | Lymph node | 59/M | + | − | + | − | + | − |
| 9 | Stomach | 68/F | + | − | + | − | + | − |
| 10 | Stomach | 56/F | + | − | + | − | + | − |
| 11 | Orbit | 57/M | + | − | + | − | − | + |
| 12 | Orbit | 71/F | + | − | + | − | + | − |
| 13 | Skin | 60/M | + | − | + | + | − | + |
| 14 | Tongue | 59/M | + | − | + | +/− | + | − |
| Case . | Site of Primary Involvement . | Age/Sex . | Immunophenotype . | |||||
|---|---|---|---|---|---|---|---|---|
| CD20 . | CD5 . | IgM . | IgD . | κ . | λ . | |||
| 1 | Spleen | 65/M | + | − | + | − | + | − |
| 2 | Spleen | 71/M | + | − | + | − | + | − |
| 3 | Spleen | 52/M | + | − | + | − | + | − |
| 4 | Spleen | 69/M | + | − | + | +/− | − | + |
| 5 | Lymph node | 84/M | + | − | +/− | − | − | + |
| 6 | Lymph node | 55/F | + | − | +/− | − | − | + |
| 7 | Lymph node | 65/M | + | − | + | − | + | − |
| 8 | Lymph node | 59/M | + | − | + | − | + | − |
| 9 | Stomach | 68/F | + | − | + | − | + | − |
| 10 | Stomach | 56/F | + | − | + | − | + | − |
| 11 | Orbit | 57/M | + | − | + | − | − | + |
| 12 | Orbit | 71/F | + | − | + | − | + | − |
| 13 | Skin | 60/M | + | − | + | + | − | + |
| 14 | Tongue | 59/M | + | − | + | +/− | + | − |